ICON Public Limited Company
ICLR
Pozycja w akcjach
#1655
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Cena akcji
$168.25
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$12.98B
Zmiana (1 dzień)
-3.93%
Zmiana (1 rok)
-9.08%
Kraj
IE
Handel ICON Public Limited Company (ICLR)
Kategoria
Healthcare
EPS dla ICON Public Limited Company (ICLR)
EPS na dzień June 2026 TTM: $4.29
Według najnowszych raportów finansowych i ceny akcji firmy ICON Public Limited Company, obecny EPS (TTM) wynosi $4.29. Na koniec roku 2023 firma miała EPS w wysokości $7.46, wzrost w porównaniu do do EPS z roku 2022, który wynosił $6.20.
Historia EPS dla ICON Public Limited Company od 2001 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $4.29 | -55.31% |
| 2024 | $9.60 | 28.69% |
| 2023 | $7.46 | 20.32% |
| 2022 | $6.20 | 171.93% |
| 2021 | $2.28 | -63.75% |
| 2020 | $6.29 | -8.18% |
| 2019 | $6.85 | 14.93% |
| 2018 | $5.96 | 14.62% |
| 2017 | $5.20 | 9.47% |
| 2016 | $4.75 | 16.42% |
| 2015 | $4.08 | 45.71% |
| 2014 | $2.80 | 65.68% |
| 2013 | $1.69 | 83.70% |
| 2012 | $0.92 | 142.11% |
| 2011 | $0.38 | -73.97% |
| 2010 | $1.46 | -9.32% |
| 2009 | $1.61 | 20.15% |
| 2008 | $1.34 | -31.28% |
| 2007 | $1.95 | 44.44% |
| 2006 | $1.35 | 486.96% |
| 2005 | $0.23 | -88.14% |
| 2004 | $1.94 | 25.16% |
| 2003 | $1.55 | 27.05% |
| 2002 | $1.22 | 25.77% |
| 2001 | $0.97 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $18.62 | 334.03% |
US
|
|
| $5.65 | 31.70% |
US
|
|
| $-1.36 | -131.70% |
US
|
|
| - | - |
CN
|
|
| $5.09 | 18.65% |
US
|
